Abstract

P1.04-39 Molecular Characteristics, Immunophenotype, and Immune Checkpoint Inhibitor Response in BRAF Non-V600 Mutant Lung Cancers

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
555 Challenges in predicting ICI response in HPV+ HNSCC: insights into the tumor microenvironment
Anastasiia Nikitina ... Nathan Fowler
Journal for ImmunoTherapy of Cancer | VOL. 11
Anastasiia Nikitina, et. al.Anastasiia Nikitina ... Nathan Fowler
01 Nov 2023
536 Decoupling cytotoxic T lymphocyte and exhausted T lymphocyte transcriptomic signatures enhances immune checkpoint inhibitors response prediction in melanoma
Binbin Wang ... Peng Jiang
Journal for ImmunoTherapy of Cancer | VOL. 10
Binbin Wang, et. al.Binbin Wang ... Peng Jiang
01 Nov 2022
Abstract LB176: Interrogating the single cell immune checkpoint inhibition atlas to decipher ICI response mechanisms
Piotr Topolewski ... Marlena Osipowicz
American Journal of Cancer | VOL. 83
Piotr Topolewski, et. al.Piotr Topolewski ... Marlena Osipowicz
14 Apr 2023
Abstract 2316: A deep Gaussian process (DGP)-based prediction model for immunecheckpoint inhibitor (ICI) response in gastric cancer (GC)
Sunho Park ... Tae Hyun Hwang
American Journal of Cancer | VOL. 84
Sunho Park, et. al.Sunho Park ... Tae Hyun Hwang
22 Mar 2024
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
Soyeong Jun ... Maximilian Diehn
Journal of Thoracic Oncology | VOL. -
Soyeong Jun, et. al.Soyeong Jun ... Maximilian Diehn
05 Jul 2024
PP01.133 Clinical and Economic Outcomes Associated with Genomic Testing Strategies in Real-World Data in Advanced Non-Small Cell Lung Cancer (aNSCLC)
Benjamin Levy ... Teddy Saliba
Journal of Thoracic Oncology | VOL. 19
Benjamin Levy, et. al.Benjamin Levy ... Teddy Saliba
01 Jul 2024
PP01.99 Switching to Subcutaneous (SC) Atezolizumab After Intravenous (IV) Dosing: Evaluation of Atezolizumab Pharmacokinetics (PK) Using Population PK Modeling
Stephanie N Liu ... Benjamin Wu
Journal of Thoracic Oncology | VOL. 19
Stephanie N Liu, et. al.Stephanie N Liu ... Benjamin Wu
01 Jul 2024
PP01.11 Real-world treatment patterns and outcomes among unresectable Stage III Non-Small Cell Lung Cancer
Ashwini Arunachalam ... Jerome Goldschmidt
Journal of Thoracic Oncology | VOL. 19
Ashwini Arunachalam, et. al.Ashwini Arunachalam ... Jerome Goldschmidt
01 Jul 2024
View more papers